A national resource for tomorrow’s treatments – Karolinska ATMP Center is now inaugurated

With a clear message of hope for the future and a powerful spirit of collaboration, the Karolinska ATMP Center in Flemingsberg was inaugurated at the end of August. The center is a collaboration between Karolinska Institutet and Karolinska University Hospital and will serve as a national resource for the production of advanced therapies (ATMPs), where research, clinical trials, and treatments work seamlessly together to deliver groundbreaking therapies to patients.

“While others back into the future, we lead the way forward—with curiosity, with science, with knowledge, but also compassion as our guiding star,” said Aida Hadžialić, Finance Regional Councilor and Chair of the Regional Executive Board in Region Stockholm, at the inauguration.

More than 600 participants from industry, academia, municipalities, and society gathered in Flemingsberg to celebrate the shared goal: accelerating the development and accessibility of tomorrow’s treatments.

“Advanced therapies represent a paradigm shift. They offer possibilities that were previously unimaginable,” stated Annika Östman Wernerson, President of Karolinska Institutet.

Throughout the day, ongoing research and breakthroughs were presented in cell and gene therapy, treatment of neonatal lung disease, Parkinson’s disease, and immunotherapies. The program highlighted the pioneering progress already being made within ATMP in Flemingsberg, where the center symbolizes a major investment in accelerating the work of future medicine even further. Knut Steffensen, Director of the Karolinska ATMP Center, summarized the vision:

“We will cure and alleviate tomorrow, what no one can cure and alleviate today.”

With the Karolinska ATMP Center now officially inaugurated, the work on future medicine takes a major step forward – where collaboration, knowledge, and compassion go hand in hand to give patients hope for a brighter future. At Flemingsberg Science Foundation, we are proud to have supported this important day for future medicine and treatments, and to celebrate all those working to drive progress forward.

The Flemingsberg Science Foundation welcomes Leslie Alfredsson as Head of Press Start and Cluster Manager in game tech

Leslie Alfredsson is an entrepreneur, innovation strategist, and game developer who is now set to take Press Start Game Hub to new heights. We are pleased to welcome Leslie as Head of Press Start, where she will continue to lead the gaming initiative that has, in a short time, established itself as a dynamic meeting place for students, researchers, and creators.

Limitless Potential: Winner of the Flemingsberg Science Award 2025

Young people in disadvantaged areas often face mental health challenges and a lack of support, which can lead to isolation and destructive choices. Limitless Potential, winner of the Flemingsberg Science Award IDEA 2025, has created a safe space where creativity and social entrepreneurship come together to support youth.

50 years of life-changing therapies

On November 12 1975, the first allogeneic bone marrrow transplantation in Sweden was performed at Huddinge Hospital, here in Flemingsberg. On November 12 1975, the first allogeneic stem cell transplantation in Sweden was performed at Huddinge Hospital, here in Flemingsberg. From nuclear catastrophe the foundations of bone marrow transplantation had emerged, and with it, the birth of modern stem cell therapy — the same principles that today underpin cell and gene therapies and CAR-T treatments.

Previous 345 Next